Description
Operator of a clinical research organization. The company focuses on the discovery and development of new products and treatments with stem cells derived from adult patients' own fat cells, known as autologous derived stem cells to help patients with various chronic and acute medical conditions.
Contact Information
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
2. Angel (individual) | 30-Jul-2015 | Cancelled | Startup | |||
1. Seed Round | 24-Jan-2013 | 00.000 | 00.000 | Completed | Startup |
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
US-20140162355-A1 | Formulations containing and kit for using adipose-derived stem cells and use thereof | Abandoned | 07-Dec-2012 | 0000000000 | 0 |
US-20160130557-A1 | Formulations containing and kit for using adipose-derived stem cells and use thereof | Abandoned | 07-Dec-2012 | 0000000000 | |
US-20160228607-A1 | Clinical applications of formulations containing adipose-derived stem cells | Granted | 07-Dec-2012 | 00000000000 | 0 |
US-9956317-B2 | Clinical applications of formulations containing adipose-derived stem cells | Active | 07-Dec-2012 | A61L27/3687 | 0 |
Name | Representing | Role | Since |
---|---|---|---|
David Bizousky MD | Antria | Medical Monitor & Board Member | 000 0000 |
Leonard Maliver MD | Antria | Chief Executive Officer & Board Member | 000 0000 |